CBP: Hermitage Capital’s Browder has right to enter USWorld October 24, 3:56
US doesn't allow Russia to remove archive from Consulate General in San FranciscoRussian Politics & Diplomacy October 24, 1:20
Trump potentially ready to meet with Putin at APEC summitWorld October 23, 20:44
Mancini unlikely to drop Russia’s Zenit for West Ham — Italian ex-striker VialliSport October 23, 20:05
Volkswagen and Daimler inspected in European Commission’s antimonopoly probesBusiness & Economy October 23, 19:40
Baltic Fleet corvettes on long-distance voyage pass through English ChannelMilitary & Defense October 23, 18:56
South Korean chain to open 33 movie theaters in MoscowBusiness & Economy October 23, 18:41
Russian MP blasts Riga’s educational language reform ploy as ‘linguistic genocide’World October 23, 18:28
Collector robbed of masterpieces by top Russian artists worth over half a million dollarsSociety & Culture October 23, 18:04
MOSCOW, December 15. /TASS/. The clinical trials for Russia’s Ebola vaccine were successful, Anna Popova, head of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, told reporters on Thursday.
"The Ebola vaccine has passed clinical trials successfully, documents for its registration are being prepared. It showed very good results," she said.
The first phase of clinical trials for the Ebola vaccine developed by the Novosibirsk-based Vector State Research Center of Virology and Biotechnology ended in June 2016, while the second began on September 8 and ended on December 8.
According to the World Health Organization (WHO), the Ebola outbreak recorded in West Africa in 2014-2015 took the lives of more than 11,000, while over 28,000 have been infected with the disease. The bulk of fatal cases occurred in Liberia, Sierra Leone and Guinea. According to the WHO, that was the largest Ebola outbreak in history.
Founded in 1974, the Vector Research Center of Virology and Biotechnology is one of the largest of its kind in the world. Initially, it studied the pathogens of such deadly diseases as anthrax and tularemia in order to develop biological weapons on their basis. Currently, Vector is developing means to diagnose and treat infectious diseases. The center’s experts are working on vaccines against swine flu, HIV and Ebola.